Estabrook Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14
| Closed | -$44 | – | 408 |
|
|
2022
Q4 | $44 | Hold |
14
| – | – | ﹤0.01% | 420 |
|
|
2022
Q3 | $69 | Hold |
14
| – | – | ﹤0.01% | 418 |
|
|
2022
Q2 | $58 | Hold |
14
| – | – | ﹤0.01% | 422 |
|
|
2022
Q1 | $81 | Hold |
14
| – | – | ﹤0.01% | 413 |
|
|
2021
Q4 | $105 | Hold |
14
| – | – | ﹤0.01% | 440 |
|
|
2021
Q3 | $126 | Hold |
14
| – | – | ﹤0.01% | 315 |
|
|
2021
Q2 | $168 | Hold |
14
| – | – | ﹤0.01% | 313 |
|
|
2021
Q1 | $175 | Hold |
14
| – | – | ﹤0.01% | 318 |
|
|
2020
Q4 | $218 | Hold |
14
| – | – | ﹤0.01% | 327 |
|
|
2020
Q3 | $132 | Hold |
14
| – | – | ﹤0.01% | 318 |
|
|
2020
Q2 | $125 | Hold |
14
| – | – | ﹤0.01% | 332 |
|
|
2020
Q1 | $89 | Hold |
14
| – | – | ﹤0.01% | 332 |
|
|
2019
Q4 | $117 | Buy |
+14
| New | +$117 | ﹤0.01% | 339 |
|